These subtypes are defined by the relative expression of four key transcriptional regulators: ASCL1-high (SCLC-A), NEUROD1-high (SCLC-N), POU2F3-high (SCLC-P), and YAP1-high (SCLC-Y) [2]. This evidence concerns the gene ASCL1 and small cell lung carcinoma.